Resumen de acción COO
The Cooper Companies, Inc., junto con sus filiales, desarrolla, fabrica y comercializa lentes de contacto.
| Puntuación del copo de nieve | |
|---|---|
| Valoración | 2/6 |
| Crecimiento futuro | 3/6 |
| Resultados anteriores | 4/6 |
| Salud financiera | 5/6 |
| Dividendos | 0/6 |
Recompensas
Análisis de riesgos
No se han detectado riesgos en COO a partir de nuestros controles de riesgos.
Competidores de The Cooper Companies, Inc.
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | US$94.14 |
| Máximo en 52 semanas | US$104.07 |
| Mínimo de 52 semanas | US$75.94 |
| Beta | 0.98 |
| 11 mes Cambio | 3.50% |
| Variación en 3 meses | -3.26% |
| Cambio de 1 año | 2.06% |
| 3Variación en 3 años | -15.22% |
| Variación en 5 años | 17.06% |
| Variación desde la OPV | 1,120.51% |
Noticias y actualizaciones recientes
Investors Interested In The Cooper Companies, Inc.'s (NASDAQ:COO) Earnings
Aug 17
Is There Now An Opportunity In The Cooper Companies, Inc. (NASDAQ:COO)?
Jul 30Is There An Opportunity With The Cooper Companies, Inc.'s (NASDAQ:COO) 36% Undervaluation?
Jun 20Cooper Companies: Business Growth Noted, Valuations An Ask
Jun 14Recent updates
Investors Interested In The Cooper Companies, Inc.'s (NASDAQ:COO) Earnings
Aug 17Is There Now An Opportunity In The Cooper Companies, Inc. (NASDAQ:COO)?
Jul 30Is There An Opportunity With The Cooper Companies, Inc.'s (NASDAQ:COO) 36% Undervaluation?
Jun 20Cooper Companies: Business Growth Noted, Valuations An Ask
Jun 14Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital
May 21With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For
May 02Should You Think About Buying The Cooper Companies, Inc. (NASDAQ:COO) Now?
Apr 17The Cooper Companies: Rating Upgrade As Near-Term Momentum Should Continue
Mar 22Calculating The Intrinsic Value Of The Cooper Companies, Inc. (NASDAQ:COO)
Mar 18The Cooper Companies: I Still Don't See Much Upside
Mar 01These 4 Measures Indicate That Cooper Companies (NASDAQ:COO) Is Using Debt Reasonably Well
Jan 23Cooper Companies: Women Health Business Makes Room For Growth; Path For Margin Expansion
Jan 15When Should You Buy The Cooper Companies, Inc. (NASDAQ:COO)?
Jan 08With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For
Dec 24A Look At The Fair Value Of The Cooper Companies, Inc. (NASDAQ:COO)
Nov 30Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital
Oct 30What Does The Cooper Companies, Inc.'s (NASDAQ:COO) Share Price Indicate?
Sep 28Cooper Offers A Great Business But A Somewhat Tricky Valuation
Sep 25Here's Why Cooper Companies (NYSE:COO) Can Manage Its Debt Responsibly
Sep 10Calculating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)
Aug 23Cooper Companies (NYSE:COO) Is Reinvesting At Lower Rates Of Return
Jul 24The Cooper Companies: Valuation Is Too High (Rating Downgrade)
Jul 12When Should You Buy The Cooper Companies, Inc. (NYSE:COO)?
Jun 24Is Cooper Companies (NYSE:COO) Using Too Much Debt?
Jun 08Estimating The Intrinsic Value Of The Cooper Companies, Inc. (NYSE:COO)
May 24Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital
Apr 23At US$355, Is The Cooper Companies, Inc. (NYSE:COO) Worth Looking At Closely?
Mar 25These 4 Measures Indicate That Cooper Companies (NYSE:COO) Is Using Debt Reasonably Well
Feb 04Cooper Companies: Growth Comes At A High Cost To Equity Holders, Rate Hold
Jan 30Estimating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)
Jan 19Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital
Jan 04Cooper Cos. initiated at buy at Mizuho on contact lenses, cataract implants positioning
Dec 22Is It Too Late To Consider Buying The Cooper Companies, Inc. (NYSE:COO)?
Dec 20The Cooper Companies declares $0.03 dividend
Dec 14The Cooper Companies Non-GAAP EPS of $2.75 misses by $0.36, revenue of $848.1M beats by $9.22M
Dec 08Cooper Companies: Questions On Viability Of Future Earnings Upside
Nov 04Are Investors Undervaluing The Cooper Companies, Inc. (NYSE:COO) By 38%?
Oct 18BioSkryb, Cooper ink license deal for genomic technology for women's reproductive health
Oct 18Be Wary Of Cooper Companies (NYSE:COO) And Its Returns On Capital
Oct 03The Cooper Companies Non-GAAP EPS of $3.19 misses by $0.04, revenue of $843.4M beats by $13.18M
Aug 31Is Now The Time To Look At Buying The Cooper Companies, Inc. (NYSE:COO)?
Aug 30Cooper Companies: The Perfect Harbor For A Perfect Storm
Aug 18Cooper Companies (NYSE:COO) Seems To Use Debt Quite Sensibly
Aug 03Rentabilidad de los accionistas
| COO | US Medical Equipment | Mercado US | |
|---|---|---|---|
| 7D | 1.1% | 2.7% | 3.9% |
| 1Y | 2.1% | 10.5% | 25.3% |
Rentabilidad vs. Industria: Los resultados de COO fueron inferiores a los de la industria US Medical Equipment, que obtuvo un rendimiento del 9.3% el año pasado.
Rentabilidad vs. Mercado: COO obtuvo unos resultados inferiores a los del mercado US, que fueron del 24.9% el año pasado.
Volatilidad de los precios
| COO volatility | |
|---|---|
| COO Average Weekly Movement | 3.0% |
| Medical Equipment Industry Average Movement | 8.4% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.1% |
| 10% least volatile stocks in US Market | 3.2% |
Precio estable de las acciones: COO no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de COO (3%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1958 | 15,000 | Al White | www.coopercos.com |
The Cooper Companies, Inc., junto con sus filiales, desarrolla, fabrica y comercializa lentes de contacto. La empresa opera en dos segmentos, CooperVision y CooperSurgical. El segmento CooperVision ofrece lentes esféricas, que incluyen lentes que corrigen la miopía y la hipermetropía; y lentes tóricas y multifocales, que incluyen lentes que corrigen problemas de visión, como el astigmatismo, la presbicia y la miopía en América, Europa, Oriente Medio, África y Asia-Pacífico.
Resumen de fundamentos de The Cooper Companies, Inc.
| Estadísticas fundamentales de COO | |
|---|---|
| Capitalización bursátil | US$18.32b |
| Beneficios(TTM) | US$339.90m |
| Ingresos (TTM) | US$3.73b |
55.1x
Ratio precio-beneficio (PE)5.0x
Ratio precio-ventas (PS)¿Está COO sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de COO | |
|---|---|
| Ingresos | US$3.73b |
| Coste de los ingresos | US$1.26b |
| Beneficio bruto | US$2.47b |
| Otros gastos | US$2.13b |
| Beneficios | US$339.90m |
Últimos beneficios comunicados
Apr 30, 2024
Próxima fecha de beneficios
Aug 28, 2024
| Beneficios por acción (BPA) | 1.71 |
| Margen bruto | 66.23% |
| Margen de beneficio neto | 9.11% |
| Ratio deuda/patrimonio | 34.7% |
¿Cómo se ha desempeñado COO a largo plazo?
Ver rendimiento histórico y comparativa